Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Arm, Open-Label, IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis (ALS)

NCT06645197 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06645197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06645197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Arm, Open-Label, IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis (ALS)
Lead sponsor
Peking University Third Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 16, 2024
Completion date
October 15, 2029
Enrollment
7 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis (als)